Phase 4Not yet recruitingNCT06600776
Ultra-rapid lispro timing in MiniMed 780G
Tel Aviv pilot trial comparing mealtime versus post-meal dosing of ultra-rapid lispro in adults using the MiniMed 780G hybrid closed-loop system.
Primary endpoints
- Percentage of time in range 70-180 mg/dL
Results so far
No results posted yet.